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Influence of hemodialysis membrane type on pentosidine has been recently demonstrated that enhanced AGE
plasma level, a marker of “carbonyl stress.” production resulted from the accumulation in uremic
Background. The accumulation of advanced glycation end plasma of carbonyl AGE precursors, a so-called “car-products (AGEs) in uremia has been ascribed to the retention
bonyl stress” [3, 4]. These various carbonyl intermediatesof carbonyl precursors of AGEs. Pentosidine plasma level has
are derived from carbohydrates, as well as from lipidbeen identified as a surrogate marker of carbonyl precursors
(“carbonyl stress”). The influence of hemodialysis (HD) mem- sources [4–6]. The mechanisms influencing the level of
brane type and residual diuresis on carbonyl stress has not carbonyl intermediates and thus the “carbonyl stress” in
been studied. renal failure have become new targets of investigation.Methods. We measured protein-linked and free plasma pen-
The diversity of the carbonyl precursors in uremictosidine (a surrogate marker of carbonyl stress) by high-per-
serum limits the current investigation of this area. Fortu-formance liquid chromatography in patients on HD with
low-flux cellulose (N 5 29), high-flux polysulfone (PS; N 5 nately, we previously discovered that pentosidine levels
57), polymethylmethacrylate (PMMA) (N 5 25), and AN69 were highly correlated with the level of precursor car-
(N 5 15).
bonyls in uremic plasma [3]. Hence, we concentrated inResults. Both protein-linked and free pentosidine were simi-
this study on the determinants of plasma pentosidinelar on low-flux cellulose, high-flux PMMA, and AN69, but were
lower (P , 0.01) on high-flux PS. Pentosidine levels were level used as markers of carbonyl precursors in the
virtually identical on Fresenius and Asahi PS in Japanese and plasma of patients treated by hemodialysis (HD).
Belgian patients. By multivariate analysis, only the type of HD
membrane and residual diuresis proved to be independent
determinants (P , 0.001) of pentosidine levels. During a single METHODS
HD session, the clearance of free pentosidine was similar with
Patientsall membranes. In three patients who were switched from AN69
to PS, the protein-linked pentosidine level dropped to the con- A total of 126 patients on three times per week mainte-
trol level after resumption of the AN69 membrane.
nance HD (69 males and 57 females) either in BelgiumConclusions. Both HD membrane type and residual diuresis
(N 5 29) or Japan (N 5 97) were studied. Their meanare independent determinants of pentosidine plasma level,
which is a marker of carbonyl stress. age was 61.2 6 13.0 (sd) years. Only two of them suffered
from mild type II diabetes. All were on HD with the
same membrane type for three months or more (or from
Renal failure is characterized by elevated levels of the onset of HD in the few patients on HD for less than
advanced glycation end products (AGEs). AGEs modify 3 months). Dialyzers were reused in 26 out of 29 Belgian
proteins from both a structural and a functional point patients but in none of the Japanese patients. Residual
of view, and thus contribute to uremic toxicity [1, 2]. It diuresis (ml/day), the surface of the dialyzer, and the
duration of HD session in each patient were retrieved
from the medical charts.
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burg, Germany) and Asahi (APS group; Tokyo, Japan), on the one hand and residual diuresis on the other was
analyzed by generalized linear regression analysis. Thehigh-flux polymethylmethacrylate from Toray (PMMA
group; Tokyo, Japan), and low-flux cellulose from Asahi independent effect of each explanatory variable on the
dependent variables (pentosidine/prot and free pentosi-(cellulosic group; Tokyo, Japan).
dine) was assessed using forward stepwise multiple re-
Plasma samples gression analysis with four dummy variables as indicators
of the type of membrane; the fifth membrane corre-Plasma samples were obtained prior to the first weekly
sponded to all four dummy variables equal to zero. ThoseHD in all 126 patients and after the same session in 66
dummy variables were forced into the regression equa-patients.
tion before testing other variables and could not beAll samples were centrifuged rapidly, frozen at 2208C,
removed thereafter. First-order interactions betweenand forwarded to the Tokai Laboratory for Cellular and
dummy variables and explanatory variables were alsoMolecular Nephrology for analysis.
considered as potential covariates for regression. Such
Measurements of total and free pentosidine an analysis is a more general approach to compare the
different membranes than a two-way analysis of vari-For quantitation of total pentosidine, the sample (50
ance, because it allows one to control for the effects ofml) was lyophilized and hydrolyzed by 100 ml of 6 N
dummy covariates as well as continuous covariates; theHCl for 16 hours at 1108C under nitrogen, followed by
two-way analysis of variance is a special linear regressionneutralization with 100 ml of 5 N NaOH and 200 ml of
in which only dummy variables (main effects and interac-0.5 m phosphate buffer (pH 7.4), and then the sample
tions) are considered. An explanatory variable was con-was filtered through a 0.5 mm-pore filter and diluted 20
sidered as having an independent effect on the depen-times with phosphate-buffered saline (PBS). For quanti-
dent variable if it led to a significant reduction intation of free-form pentosidine, the sample (50 ml) was
likelihood ratio statistics, and the effect was reported asmixed with an equal volume of 10% trichloroacetic acid
partial correlation coefficient r. All analyses were per-(TCA) and centrifuged at 5000 3 g for 10 minutes. The
formed using the BMDP statistical software [8]. P valuessupernatant was filtered through a 0.5 mm filter and di-
of less than 0.05 were considered significant.luted four times with distilled water. Pentosidine in these
specimens was analyzed by reverse-phase high-perfor-
mance liquid chromatography (HPLC) [7]. Briefly, a 50 RESULTS
ml solution of acid hydrolysate of plasma (corresponding
The characteristics of the five groups of patients ofto 25 mg of proteins) or diluted protein-free plasma (cor-
the cross-sectional study are listed in Table 1.responding to 6.25 ml of plasma) was injected into an
The groups do not differ significantly from each otherHPLC system and separated on a C18 reverse-phase
for age. Plasma protein level was higher in the AN69column (Waters, Tokyo, Japan). The effluent was moni-
and cellulosic groups; dialyzer surface, duration of HDtored using a fluorescence detector (RF-10A; Shimadzu)
prior to the study, and duration of HD session wereand an excitation-emission wavelength of 335/385 nm.
larger or longer in the APS group, whereas residualSynthetic pentosidine was used to obtain a standard
diuresis was higher in the PS group.curve.
Predialysis plasma levels of protein-bound and freeProtein-linked pentosidine (pentosidine/prot; pmol/mg
pentosidine were similar in the AN69, PMMA, and cellu-protein) was calculated as follows:
losic groups and were significantly lower in the PS and
APS groups. There was no significant difference betweenTotal plasma pentosidine 2 Free pentosidine (pmol/ml)
Plasma protein concentration (mg/ml) the two latter groups (Table 2).
Univariate analysis of the various factors that might
Statistical analysis influence predialysis plasma pentosidine levels disclosed
a significant influence of residual diuresis on protein-Results are presented as means 6 sd or as percentages.
Residual diuresis data were log transformed before sta- bound and free pentosidine: the higher the diuresis, the
lower the pentosidine levels. Neither plasma protein nortistical analysis. The individual characteristics and pen-
tosidine levels were compared between groups of pa- albumin levels, nor age nor duration of prior dialysis was
correlated with pentosidine levels (Table 3). In the PStients on HD with different membranes by one-way
analysis of variance (with F tests). Further analyses were groups (PS–APS), predialysis pentosidine levels were
similar in Belgian and in Japanese subjects whether givenperformed to compare membrane groups two by two,
using a Bonferroni criterion. The frequency of the persis- Fresenius or Asahi PS dialysis (Table 4).
Forward stepwise multiple regression analysis con-tence of residual diuresis was compared between the
various groups by a chi-square test. The relationship firmed the result of the previous analyses. Membrane
type and residual diuresis were the two sole, independentbetween the pentosidine/prot and free pentosidine level
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Table 1. Characteristics of the five groups of patients dialyzed with different membranes
APS PS AN69 PMMA Cellulosic ANOVA
N 5 29 N 5 28 N 5 15 N 5 25 N 5 29 P value
Age years 58612 61613 6467 61613 64616 NS
Time on HD years 13.767.5g 5.466.8 7.866.7 9.266.5 5.564.4 ,0.001
Protein plasma level g/dl 6.760.5b 6.360.7 6.860.6 6.260.3c 7.060.4a ,0.001
Albumin plasma level g/dl 3.960.3e 3.660.4d 3.960.4f 3.660.3 4.260.3a ,0.001
Duration of HD session hours 4.560.23h 3.9860.40 4.1360.23 4.0460.48 4.0060.00 ,0.001
Surface of hemodialyzer m2 1.8 1.2860.36 1.4260.34 1.3160.32 1.3260.24 NDj
Residual diuresis ml/day
Geometric mean (sd) 47 (10) 213 (250)i 34 (13) 47 (8) 26 (8) ,0.001
(Range) (0–800) (0–3050) (0–500) (0–400) (0–400)
x2
P value
Prevalence of residual diuresis % 33% 50%i 20% 28% 17% ,0.001
Abbreviations are: APS, high-flux polysulfone membrane manufacturered by Asahi (Japan); PS, polysulfone membrane from Fresenius (Germany); AN69, high-
flux membrane from Hospal (France); PMMA, high-flux polymethacrylate from Toray (Japan); cellulose, low-flux cellulose from Asahi; HD, hemodialysis.
a P , 0.001 vs. PS and PMMA groups
b P , 0.001 vs. PMMA group
c P , 0.05 vs. AN69 group
d P , 0.05 vs. APS group
e P , 0.01 vs. PMMA and cellulosic group
f P , 0.05 vs. cellulosic group
g P , 0.01 vs. all other groups
h P , 0.001 vs. all other groups
i P , 0.05 vs. cellulosic group
j The surface of the hemodialyzer cannot be considered as a random variable as it is fixed by the physician; therefore, it cannot be compared by a statistical test
Table 2. Pre-dialysis pentosidine levels in the five membrane groups
APS PS AN69 PMMA Cellulosic ANOVA
N 5 29 N 5 28 N 5 15 N 5 25 N 5 29 P value
Pentosidine/prot pmol/mg prot 16.264.8 1566.1 25.468.4a 23.269.3a 21.766.3a ,0.001
Free pentosidine pmol/ml 32.4611.3 41.4622.9 76.4628.5a 68.8626.7a 53.7618.2a ,0.001
Abbreviations are in Table 1.
a P , 0.01 vs. PS and APS groups
Table 3. Univariate analysis of the relationship between pentosidine but the percentage decrease was similar in all groups,
level and potentially explanatory continuous variables:r values ranging from 76% with AN69 to 67% with PMMA (not
logDIU Total protein Albumin Age Duration significant). Thus, an improved clearing ability of the
membrane could not account for the lower predialysisPentosidine/protein 20.28a 20.08 0 0.14 0.03
Free pentosidine 20.36b 0.01 20.12 0.15 0.02 pentosidine levels observed in PS-treated patients.
a P , 0.01 To confirm a specific pentosidine-lowering effect of
b P , 0.001 PS, a longitudinal study was performed in three anuric
patients given long-term (more than five years) AN69
dialysis. The patients were switched to a PS (Fresenius)
dialyzer of similar surface area for 10 weeks and thendeterminants of predialysis protein-bound and free pen-
returned to AN69. Predialysis samples were obtainedtosidine (Table 5). None of the interactions were signifi-
every two weeks prior to the switch (two samples), duringcant; thus, the influence of residual diuresis on pentosi-
PS dialysis (five samples), and 14 to 16 weeks after re-dine level was not affected by membrane type.
sumption of AN69 (two samples). The protein-boundTo further evaluate the mechanism of the membrane
pentosidine level fell progressively in each patient aftereffect on predialysis pentosidine levels, the predialysis
switching to PS to return to control level after resump-
and postdialysis levels of pentosidine were evaluated in tion of AN69 dialysis (Fig. 1).
four groups of patients given either high-flux PS (Fresen-
ius), AN69, PMMA, or low-flux cellulosic dialysis (Table
DISCUSSION6). As anticipated from previous studies, protein-bound
pentosidine changed very little, irrespective of mem- The most striking, and rather unexpected, observation
of this study is that pentosidine levels are lower in pa-brane type. Only free pentosidine decreased markedly,
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Table 4. Pentosidine levels and residual diuresis in polysulfone groups, according to polysulfone brand and/or country of patients
Fresenius Fresenius Asahi
Belgium Japan Japan P value
Pentosidine/protein pmol/mg prot 14.666.2 15.366.3 16.2 64.8 NS
Free pentosidine pmol/ml 37.3619.6 45.4625.9 32.4 611.3 NS
Residual diuresis ml/day 938 (23) 49 (14) 47 (10) 0.004
Table 5. Forward stepwise multiple regression analysis of post-HD pentosidine levels for all membranes suggests
determinants of pentosidine levels
that not only diffusive transport, but also the adsorption
Pentosidine/protein Free pentosidine of pentosidine is similar during dialysis with PS and with
Increase in R P value Increase in R P value the other membranes. In vitro, radiolabeled free pentosi-
dine adsorption is minimal and virtually identical forMembrane type 0.53 ,0.001 0.59 ,0.001
Log. diuresis 20.21 ,0.001 20.36 ,0.001 cellulose and PS membranes (T. Miyata, unpublished
Total protein 20.17 NS 0.05 NS observation).Albumin 20.05 NS 20.1 NS
Thus, improved removal of pentosidine by PS mem-Age 0.12 NS 0.16 NS
Time on HD 20.01 NS 20.08 NS branes does not seem to account for the lower predialysis
levels. Alternatively, it is possible that PS dialysis is asso-
ciated with a lower production of pentosidine.
As pointed out, pentosidine levels reflect the concen-
tients given PS dialysis than in those treated with several tration of carbonyl precursors derived from carbohy-
other membranes. The observation that pentosidine lev- drates. PS membranes might have a specific effect on
els are lower both in Belgian and in Japanese patients the removal of these carbonyls and therefore on pento-
treated with PS membranes produced by two different
sidine production. Alternatively, PS membranes might
companies strengthens this observation.
decrease the oxidative stress reportedly associated withThe observed difference cannot be accounted for by
uremia [5, 6, 10–13]. A lowered oxidative stress mightdifferences in residual diuresis. Indeed, the stepwise mul-
reduce the production of carbonyls and thus of pentosi-tiple regression analysis demonstrates an independent
dine [6].effect of membrane and residual diuresis on pentosidine
The fall in pentosidine levels observed after switchinglevels. Furthermore, although patients given Asahi PS
patients from AN69 to PS dialysis in the longitudinaldialysis are virtually anuric, their pentosidine level is
study is only one third of the difference observed be-equally low. In the Fresenius PS group, exclusion of
tween the PS and the AN69 groups in the cross-sectionalpatients with a residual diuresis above 300 ml/min does
study (3.6 vs. 10.4 pmol/mg protein). This discrepancynot modify the statistical significance of the differences
might be related to the fact that the observation periodof pentosidine levels. Finally, the longitudinal study dis-
on PS lasted only 10 weeks. Such a slow fall of protein-closes a membrane-related effect on pentosidine levels
bound pentosidine is to be expected if PS decreases thein all three patients switched from high-flux AN69 to
generation rate of pentosidine. Under those circum-high-flux PS. Still, the interpretation of these results re-
stances, the protein-bound pentosidine level will de-quires confirmation.
crease only to the extent that the protein is catabolized.No obvious explanation can account for these results.
A similar observation was made after successful renalThe effect is unrelated to the porosity of the membrane
transplantation. The fall in protein-bound pentosidinebecause AN69 is also a high-flux membrane. Further-
was markedly delayed [9, 14] when compared with themore, both high-flux AN69 and low-flux cellulosic dial-
fall in serum b2 microglobulin, an observation taken toysis result in similar predialysis pentosidine levels.
illustrate the slow decay of protein-bound pentosidine.More specifically, pentosidine levels appear indepen-
Pentosidine is a marker of carbohydrate-derived car-dent of the ability of the membrane to clear pentosidine.
bonyl precursors. It has been recently demonstrated thatWe had previously shown that HD itself does not modify
the uremia-associated “carbonyl stress” also results fromtotal or protein-bound pentosidine [9], a finding in agree-
the accumulation of lipid-derived carbonyl precursorsment with the fact that over 95% of pentosidine is bound
[4, 5]. It remains to be demonstrated that PS membranesto nondiffusible albumin [7]. These data confirm this
have a similar effect on those precursors.finding with four different types of membranes. By con-
These data provide the first indication that residualtrast, free pentosidine decreases during HD, but this
renal function is a critical determinant of serum pentosi-phenomenon is similar with all membranes, a result to be
dine levels and thus of its carbonyl precursors. A similarexpected when the molecular weight of free pentosidine
(379 Da) is considered. The similarity of the pre-HD/ role of residual renal function has been previously dem-
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Table 6. Influence of a single hemodialysis session on pentosidine level
PS AN69 PMMA Cellulosic
N 5 14 N 5 15 N 5 9 N 5 28
Pentosidine/protein pmol/mg prot
Pre 14.666.2 25.468.4 24.368.5 21.866.4
Post 13.866.6 23.465.6 22.868.3 22.165.8
Free pentosidine pmol/ml
Pre 37.3619.6 76.4628.5 70.3626 53.5618.5
Post 10.966.6 17.564.9 21.767 14.766.9
Reduction ratio % (71611) (7667) (6769) (7366)
Reprint requests to Michel Jadoul, M.D., Cliniques Universitaires St.
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